Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589988 | SCV000696939 | uncertain significance | not provided | 2017-07-13 | criteria provided, single submitter | clinical testing | Variant summary: The CFTR c.2976T>A (p.Phe992Leu) variant causes a missense change involving the alteration of a conserved nucleotide. 2/4 in silico tools predict a benign outcome for this variant. This variant was found in 2/121164 control chromosomes at a frequency of 0.0000165, which does not exceed the estimated maximal expected allele frequency of a pathogenic CFTR variant (0.0062697). The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS). |
Fulgent Genetics, |
RCV002506399 | SCV002816734 | uncertain significance | Bronchiectasis with or without elevated sweat chloride 1; Cystic fibrosis; Hereditary pancreatitis; Congenital bilateral aplasia of vas deferens from CFTR mutation | 2021-09-22 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834845 | SCV002083570 | uncertain significance | CFTR-related disorder | 2019-02-26 | no assertion criteria provided | clinical testing |